# TAZVERIK
> **NDA213400** · New Drug Application · Sponsor: EPIZYME INC · Approved 2020-06-18
## Drug
- **FDA Application Number:** NDA213400
- **Application type:** New Drug Application
- **Brand name:** TAZVERIK
- **Generic name:** Tazemetostat Hydrobromide
- **Active ingredients:** TAZEMETOSTAT HYDROBROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EPIZYME INC
- **First approval:** 2020-06-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213400)
---
*MORVS · CC0 1.0*